Compare EYPT & ASA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | EYPT | ASA |
|---|---|---|
| Founded | 1987 | 1958 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Laboratory Analytical Instruments | Precious Metals |
| Sector | Industrials | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 967.4M | 905.1M |
| IPO Year | 2005 | N/A |
| Metric | EYPT | ASA |
|---|---|---|
| Price | $14.74 | $52.57 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $29.60 | N/A |
| AVG Volume (30 Days) | ★ 1.3M | 75.8K |
| Earning Date | 11-05-2025 | 12-09-2025 |
| Dividend Yield | N/A | ★ 0.11% |
| EPS Growth | N/A | ★ 335.96 |
| EPS | N/A | ★ 19.90 |
| Revenue | ★ $42,339,000.00 | $3,982,215.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $2.65 |
| Revenue Growth | N/A | ★ 99.75 |
| 52 Week Low | $3.91 | $19.37 |
| 52 Week High | $14.96 | $53.76 |
| Indicator | EYPT | ASA |
|---|---|---|
| Relative Strength Index (RSI) | 65.34 | 66.37 |
| Support Level | $13.43 | $45.79 |
| Resistance Level | $14.96 | $49.33 |
| Average True Range (ATR) | 0.86 | 1.96 |
| MACD | 0.29 | 0.40 |
| Stochastic Oscillator | 93.50 | 96.34 |
EyePoint Pharmaceuticals Inc is a pharmaceutical company. It is engaged in developing and commercializing ophthalmic products for the treatment of eye diseases. The company has developed FDA-approved sustained-release treatments in ophthalmology. Its pre-clinical development program is focused on using its core Durasert E and Verisome technology platforms to deliver drugs to treat wet age-related macular degeneration, glaucoma, osteoarthritis, and other diseases. Geographically, the firm has operational footprints in the U.S., China, and the UK. It generates a majority of its revenue from the U.S.
ASA Gold And Precious Metals Ltd is a closed-end, non-diversified investment company. Its objective is to provide long-term capital appreciation through investing in companies engaged in the exploration for, development of projects, or mining of precious metals and minerals.